🇺🇸 FDA
Pipeline program

Omega 3-Atorvastatin

B-2111-720-004

Approved small_molecule active

Quick answer

Omega 3-Atorvastatin for Dyslipidemias is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Dyslipidemias
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials